Illumina sees Q4 revenue above expectations, provides a mixed outlook [MarketWatch]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: MarketWatch
Illumina sees Q4 revenue above expectations, provides a mixed outlook Illumina Inc. ILMN, -4.59% provided Wednesday a fourth-quarter revenue estimate that was above expectations, and provided a mixed outlook for 2019. The stock was still inactive in premarket trade. The genetics analysis company's Chief Executive Francis deSouza said at the J.P. Morgan Healthcare Conference that fourth-quarter revenue rose 11% from a year ago to $865 million, which was above the FactSet consensus of $862 million, while full-year revenue rose 21% to $3.3 billion. For 2019, deSouza said revenue growth is expected to be 13% to 14%, while the current FactSet consensus of $3.81 billion is about 15% above 2018 revenue of $3.3 billion. The company expects 2019 adjusted earnings per share, which excludes non-recurring items, of $6.50 to $6.60, compared with the current FactSet consensus of $6.44. Illumina's stock has lost 9.3% over the past three months, while the SPDR Health Care Select Sector ETF XLV, +
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Global Targeted Sequencing Industry Research 2023-2033: Burgeoning Opportunities Adoption in Targeted Therapeutics in Oncology and Use in Clinical Research and Trials for Better Disease Pathogenesis [Yahoo! Finance]Yahoo! Finance
- Multicancer Screening Market Projected to Reach $2.72 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]Yahoo! Finance
- Illumina's planned divestment of GRAIL approved by the European Commission [Yahoo! Finance]Yahoo! Finance
- Illumina's planned divestment of GRAIL approved by the European CommissionPR Newswire
- Microfluidic Device Market Expected to Reach US$ 657.9 Million by 2034: Fact.MR Report [Yahoo! Finance]Yahoo! Finance
ILMN
Earnings
- 2/8/24 - Beat
ILMN
Sec Filings
- 4/12/24 - Form 8-K
- 4/10/24 - Form 4
- 4/9/24 - Form 8-K
- ILMN's page on the SEC website